1. A Standardized Investigational Ki-67 Immunohistochemistry Assay Used to Assess High-Risk Early Breast Cancer Patients in the monarchE Phase 3 Clinical Study Identifies a Population With Greater Risk of Disease Recurrence When Treated With Endocrine Therapy Alone. Issue 4 (25th April 2022) Authors: Polewski, Monika D.; Nielsen, Gitte B.; Gu, Ying; Weaver, Aaron T.; Gegg, Gavin; Tabuena-Frolli, Siena; Cajaiba, Mariana; Hanks, Debra; Method, Michael; Press, Michael F.; Gottstein, Claudia; Gruver, Aaron M. Journal: Applied immunohistochemistry & molecular morphology Issue: Volume 30:Issue 4(2022) Page Start: 237 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗